Gastro Esophageal RefluxDiagnostics and screeningDiagnostic test
What this study is
The objective of this study is to design and use a novel, minimally invasive mucosal impedance (MI) technology to inexpensively and accurately test mucosal health in suspected gastroesophageal reflux disease (GERD) and nonerosive reflux disease (NERD) patients as compared to those without GERD.
What's being tested
- single catheter mucosal impedance testing
Intervention · DIAGNOSTIC TEST
- balloon assembly mucosal impedance testing
Intervention · DIAGNOSTIC TEST
Study details
- Sponsor
- Vanderbilt University Medical Center
- Conditions
- Gastro Esophageal Reflux
- Enrolling
- 75 people
- Starts
- 2014-04-29
- Est. completion
- 2027-08-31
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 99 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients who are undergoing standard of care EGD with or without BRAVO pH capsule placement
You can't join if
- Age less than 18 years old
- Patients unable to give informed consent
- Use of acid suppressive therapy within last 10 days
- Known history of Barrett's esophagus or gastric surgery, other than non-functioning (slipped) Nissen fundoplication
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openVanderbilt University Medical Center Endoscopy Laboratory
Nashville, Tennessee, United States
Study team
Sponsor
Vanderbilt University Medical Center
Study ID 140470
Principal investigator
Michael Vaezi, MD, PhD
Vanderbilt University Medical Center
Have questions? The record lists no central contact. Use Consider me and the site team can reach you, or find them through ClinicalTrials.gov ↗.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.